Dynamic changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson's disease

D Huang, J Xu, J Wang, J Tong, X Bai, H Li… - Parkinson's …, 2017 - Wiley Online Library
The characteristic brain pathology and motor and nonmotor symptoms of Parkinson's
disease (PD) are well established. However, the details regarding the causes of the disease …

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine)-induced mouse model of Parkinson's disease

H Yokoyama, H Kuroiwa, J Kasahara, T Araki - Acta neurobiologiae …, 2011 - ane.pl
Parkinson's disease (PD) is a common neurodegenerative disease that appears essentially
as a sporadic condition. PD is well known to be a chronic and progressive …

Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment

JA Korecka, R Eggers, DF Swaab… - Restorative …, 2013 - content.iospress.com
Purpose: Parkinson's disease (PD) is a movement disorder mainly characterized by
progressive neurodegeneration of dopaminergic (DAergic) neurons in the substantia nigra …

Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine

NRS Goldberg, AK Haack, NS Lim, OK Janson… - Neuroscience, 2011 - Elsevier
A number of neurotoxin-and gene-based rodent models of acute neurodegeneration of
nigrostriatal dopamine (DA) neurons are used to study Parkinson's disease (PD). The rapid …

Long-term changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson's disease

D Huang, Z Wang, J Tong, M Wang, J Wang, J Xu… - Neuroscience, 2018 - Elsevier
Parkinson's disease (PD) is a common and progressive neurodegenerative disorder. The 1-
methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of PD is widely used to …

Neurotoxin-based models of Parkinson's disease

J Bové, C Perier - Neuroscience, 2012 - Elsevier
Animal experimentation in the Parkinson's disease (PD) field is a classic example of how the
use of animal models to study diseases can have a significant impact on human health …

MPTP mouse models of Parkinson's disease: an update

GE Meredith, DJ Rademacher - Journal of Parkinson's …, 2011 - content.iospress.com
Among the most widely used models of Parkinson's disease (PD) are those that employ
toxins, especially 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Depending on the …

The MPTP mouse model: cues on DA release and neural stem cell restorative role

PA Serra, S Pluchino, B Marchetti, MS Desole… - Parkinsonism & related …, 2008 - Elsevier
1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) is known to cause parkinsonism in
humans and this fact is a major incentive for using this toxin as an animal model to study the …

Neurotoxin-induced animal models of Parkinson disease: pathogenic mechanism and assessment

XS Zeng, WS Geng, JJ Jia - ASN neuro, 2018 - journals.sagepub.com
Parkinson disease (PD) is the second most common neurodegenerative movement
disorder. Pharmacological animal models are invaluable tools to study the pathological …

Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol

GE Meredith, S Totterdell, JA Potashkin… - Parkinsonism & related …, 2008 - Elsevier
Formidable challenges for Parkinson's disease (PD) research are to understand the
processes underlying nigrostriatal degeneration and how to protect dopamine neurons …